Table 1.
Demographic, clinical data and biochemical test results in study participants
| Group I – OHSS severe (n=28) | Group II – OHSS mild/ moderate (n=78) | p value | |||||
|---|---|---|---|---|---|---|---|
| Mean ± Standard Deviation (SD) | Range (Minimum – Maximum) | Median | Mean ± SD | Range (Minimum – Maximum) | Median | ||
| Age (years) | 31.00 ± 3.45 | 24-37 | 30 | 30.74 ± 3.05 | 23-38 | 29 | NSa |
| BMI (kg/m2) | 23.26 ± 1.53 | 21.7-27.9 | 23.5 | 23.75 ± 2.24 | 20.3-28.9 | 23.7 | NS |
| Type of GnRh analogue Agonist / antagonist | 12 / 16 0.75% |
34 / 44 77.27 |
NS | ||||
| Total doses of FSH (UI) | 1709.26 ± 30 | 1200-2250 | 1700 | 1817.28 ± 41 | 1150-2650 | 1850 | NS |
| Duration of stimulation (days) | 10.63 ± 1.21 | 9-13 | 10 | 10.84 ± 0.98 | 9-13 | 11 | NS |
| Estradiol concentration on the day of HCG administration (pg/mL) | 4168.33 ± 471 | 3470-5100 | 3970 | 3914.94 ± 569 | 2890-5890 | 3900 | 0.04 |
| No. of follicles > 14mm | 22.52 ± 3.0 | 18-28 | 22 | 20.92 ± 3.7 | 12-31 | 21 | 0.03 |
| No. of oocytes retrieved | 13.07 ± 2.6 | 5-16 | 13 | 11.99 ± 2.38 | 4-18 | 12 | 0.01 |
| No. of embryos transferred | 1.8 ± 0.5 | 1-3 | 2 | 1.6 ± 0.4 | 1-3 | 2 | NS |
| Clinical pregnancy (%) | 42.8% | 38.4% | NS | ||||